Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma.


Journal

Tomography (Ann Arbor, Mich.)
ISSN: 2379-139X
Titre abrégé: Tomography
Pays: Switzerland
ID NLM: 101671170

Informations de publication

Date de publication:
22 04 2022
Historique:
received: 17 03 2022
revised: 19 04 2022
accepted: 20 04 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

Background. The aim of this study was to identify the most accurate computed-tomography (CT) dimensional criteria of loco-regional lymph nodes (LNs) for detecting nodal metastases in gastric cancer (GC) patients. Methods. Staging CTs of surgically resected GC were jointly reviewed by two radiologists, considering only loco-regional LNs with a long axis (LA) ≥ 5 mm. For each nodal group, the short axis (SA), volume and SA/LA ratio of the largest LN, the sum of the SAs of all LNs, and the mean of the SA/LA ratios were plotted in ROC curves, taking the presence/absence of metastases at histopathology for reference. On a per-patient basis, the sums of the SAs of all LNs, and the sums of the SAs, volumes, and SA/LA ratios of the largest LNs in all nodal groups were also plotted, taking the presence/absence of metastatic LNs in each patient for reference. Results. Four hundred and forty-three nodal groups were harvested during surgery from 107 patients with GC, and 173 (39.1%) were metastatic at histopathology. By nodal group, the sum of the SAs showed the best Area Under the Curve (AUC), with a sensitivity/specificity of 62.4/72.6% using Youden’s index with a >8 mm cutoff. In the per-patient analysis, the sum of the SAs of all LNs in the loco-regional nodal groups showed the best AUC with a sensitivity/specificity of 65.6%/83.7%, using Youden’s index with a >39 mm cutoff. Conclusion. In patients with GC, the sum of the SAs of all the LNs at staging CT is the best predictor among dimensional LNs criteria of both metastatic invasion of the nodal group and the presence of metastatic LNs.

Identifiants

pubmed: 35645384
pii: tomography8030098
doi: 10.3390/tomography8030098
pmc: PMC9149869
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1207

Références

Int J Clin Oncol. 2015 Apr;20(2):207-39
pubmed: 25782566
Eur Radiol. 2015 Feb;25(2):368-74
pubmed: 25097136
Lancet Oncol. 2010 May;11(5):439-49
pubmed: 20409751
World J Gastroenterol. 2013 Sep 14;19(34):5732-7
pubmed: 24039369
Ann Surg. 2015 Dec;262(6):991-8
pubmed: 25563867
J Clin Oncol. 2005 Oct 1;23(28):7114-24
pubmed: 16192595
N Engl J Med. 2008 Jul 31;359(5):453-62
pubmed: 18669424
N Engl J Med. 2001 Sep 6;345(10):725-30
pubmed: 11547741
Gastrointest Tumors. 2017 Mar;3(3-4):163-170
pubmed: 28611983
Eur Radiol. 2018 Dec;28(12):5241-5249
pubmed: 29869176
Ann Surg Oncol. 2015 Feb;22(2):557-64
pubmed: 25287440
Clin Radiol. 2019 Oct;74(10):782-789
pubmed: 31378300
Gastric Cancer. 2012 Sep;15 Suppl 1:S19-26
pubmed: 22237654
Endoscopy. 2004 Jul;36(7):617-23
pubmed: 15243885
Br J Surg. 2014 Jan;101(2):23-31
pubmed: 24375296
Ann Surg Oncol. 2013 Jun;20(6):2016-22
pubmed: 23266583
J Clin Oncol. 2007 May 20;25(15):2107-16
pubmed: 17513817
Updates Surg. 2021 Oct;73(5):1879-1890
pubmed: 34125428
J Am Coll Surg. 2015 Jan;220(1):48-56
pubmed: 25283742
J Gastrointest Oncol. 2021 Aug;12(4):1351-1362
pubmed: 34532093
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Am Coll Surg. 2014 Oct;219(4):664-75
pubmed: 25154671
Medicine (Baltimore). 2016 Sep;95(39):e5042
pubmed: 27684881
Radiother Oncol. 2020 Sep;150:89-96
pubmed: 32531334
Nucl Med Commun. 2022 Jan 1;43(1):64-72
pubmed: 34661379
Eur J Radiol. 2020 Aug;129:109069
pubmed: 32464581
Front Oncol. 2021 Sep 13;11:723345
pubmed: 34589429
J Clin Oncol. 2004 Jul 15;22(14):2774-80
pubmed: 15254045
Scand J Gastroenterol. 2004 Apr;39(4):380-4
pubmed: 15125471
Radiology. 2007 Feb;242(2):472-82
pubmed: 17255419
Int J Surg. 2018 Mar;51:120-127
pubmed: 29413875
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
J Clin Oncol. 2009 Feb 20;27(6):851-6
pubmed: 19139439
J Surg Oncol. 2016 Jun;113(7):750-5
pubmed: 26996496
J Gastroenterol Hepatol. 2015 Nov;30(11):1603-9
pubmed: 25974404
J Am Coll Surg. 2015 Aug;221(2):291-9
pubmed: 26206635
Gastrointest Endosc. 2004 May;59(6):619-26
pubmed: 15114303

Auteurs

Filippo Crimì (F)

Institute of Radiology, Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy.

Quoc Riccardo Bao (QR)

General Surgery 3, Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padova, 35128 Padova, Italy.

Valentina Mari (V)

General Surgery 3, Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padova, 35128 Padova, Italy.

Chiara Zanon (C)

Institute of Radiology, Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy.

Giulio Cabrelle (G)

Institute of Radiology, Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy.

Gaya Spolverato (G)

General Surgery 3, Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padova, 35128 Padova, Italy.

Salvatore Pucciarelli (S)

General Surgery 3, Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padova, 35128 Padova, Italy.

Emilio Quaia (E)

Institute of Radiology, Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH